Literature DB >> 173485

Induction and in Vitro demonstration of cellular immunity to DNA and RNA viruses in guinea-pigs.

U Koszinowski, G Bandlow.   

Abstract

Guinea-pigs were immunized with different cells infected with vaccinia virus, herpes simplex virus type 1, herpesvirus saimiri, and the virus of vesicular stomatitis. Development of cellular immunity against these viruses was observed with transformation of blood and spleen lymphocytes and with the migration inhibition test using peritoneal exudate cells. Cellular immunity against vaccinia virus was first seen 6 days after the inoculation of cell-bound vaccinia virus by lymphocyte transformation. The avtivation of the vaccinia virus specific cellular immune response could be induced with tissue culturrus. Since infectious virus particles are not synthesized within this time period, it is likely that virus-induced antigens in the cell surface are active in production of cellular immunity. Vaccines from heterologous host cells were more effective inducers of an immune response than syngeneic cell cultures. For in vitro testing of cellular immunity to viruses, viral antigens could be used in both infective and inactivated form. Delayed hypersensitivity to viral antigens was always accompanied by immune reactions to the host cells used for virus propagation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 173485      PMCID: PMC1538187     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  DELAYED HYPERSENSITIVITY IN VITRO. I. THE SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS.

Authors:  J R DAVID; S AL-ASKARI; H S LAWRENCE; L THOMAS
Journal:  J Immunol       Date:  1964-08       Impact factor: 5.422

2.  A clinical and experimental study of agammaglobulinemia.

Authors:  R A GOOD; R L VARCO
Journal:  J Lancet       Date:  1955-06

3.  In vitro cell migration as a model for delayed hypersensitivity.

Authors:  M GEORGE; J H VAUGHAN
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

4.  An in vitro measure of cellular immunity to fibroma virus.

Authors:  W A Tompkins; C Adams; W E Rawls
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

5.  Induction of delayed hypersensitivity to influenza and mumps viruses in mice.

Authors:  S M Feinstone; E H Beachey; M W Rytel
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

6.  A proposed classification of primary immunologic deficiencies.

Authors:  M Seligmann; H H Fudenberg; R A Good
Journal:  Am J Med       Date:  1968-12       Impact factor: 4.965

7.  Interaction between antigenically different cells. Virus-induced cytotoxicity by immune lymphoid cells in vitro.

Authors:  C Lundstedt
Journal:  Acta Pathol Microbiol Scand       Date:  1969

8.  A study of delayed hypersensitivity of guinea pigs to vaccinia virus. Comparison of inhibition of cell migration to a local passive transfer reaction for the quantification of delayed hypersensitivity.

Authors:  E I Pilchard; E E Gold; H K Gray
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

9.  [Nucleic acid and protein metabolism in lymphocyte cultures in healthy persons and patients with diseases of the lymphatic system. I. Methods and kinetic studies in healthy persons].

Authors:  K Havemann
Journal:  Z Gesamte Exp Med       Date:  1969

10.  Cellular immunity in vaccinia infection of mice. Anti-thymocyte serum effects on primary and secondary responsiveness.

Authors:  M S Hirsch; A J Nahmias; F A Murphy; J H Kramer
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

View more
  2 in total

1.  Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.

Authors:  Robert J Natuk; David Cooper; Min Guo; Priscilla Calderon; Kevin J Wright; Farooq Nasar; Susan Witko; Diane Pawlyk; Margaret Lee; Joanne DeStefano; Donna Tummolo; Aaron S Abramovitz; Seema Gangolli; Narender Kalyan; David K Clarke; R Michael Hendry; John H Eldridge; Stephen A Udem; Jacek Kowalski
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 2.  Prospects and perspectives for development of a vaccine against herpes simplex virus infections.

Authors:  Shane C McAllister; Mark R Schleiss
Journal:  Expert Rev Vaccines       Date:  2014-07-31       Impact factor: 5.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.